Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs1799971
rs1799971
0.100 GeneticVariation BEFREE The A118G polymorphism of mu-opioid receptor may be closely associated with DFU pain in 34 out of 50 patients in the painless group and in 5 out of 15 patients in the painful group. 19303332

2010

dbSNP: rs1799971
rs1799971
0.100 GeneticVariation BEFREE A common single nucleotide polymorphism (SNP), A118G, in the mu-opioid receptor gene can affect opioid function and, consequently, has been suggested to contribute to individual variability in pain management and drug addiction. 20074870

2010

dbSNP: rs1799971
rs1799971
0.100 GeneticVariation BEFREE A118G: We found that the variant G allele was associated with reduced antinociceptive effect as measured by pain tolerance thresholds to single electrical nerve stimulation (8% increase vs. 25% for the wild-type carriers, P = 0.007). 19845769

2010

dbSNP: rs1799971
rs1799971
0.100 GeneticVariation BEFREE The A118G polymorphism had a gene-dose-dependent effect on electrical pain tolerance threshold. 20003118

2010

dbSNP: rs4680
rs4680
0.100 GeneticVariation BEFREE However, genetic effects (COMT Val(158)Met and BDNF Val(66)Met) on experimental pain were moderated by the presence of chronic pain. 21049025

2010

dbSNP: rs4680
rs4680
0.100 GeneticVariation BEFREE More generally, apart from one report that focused on pain-induced opioid release, this is the first functional neuroimaging study showing an effect of the COMT val158met polymorphism on cerebral pain processing. 20509977

2010

dbSNP: rs6265
rs6265
0.060 GeneticVariation BEFREE However, genetic effects (COMT Val(158)Met and BDNF Val(66)Met) on experimental pain were moderated by the presence of chronic pain. 21049025

2010

dbSNP: rs759834365
rs759834365
0.050 GeneticVariation BEFREE However, genetic effects (COMT Val(158)Met and BDNF Val(66)Met) on experimental pain were moderated by the presence of chronic pain. 21049025

2010

dbSNP: rs6746030
rs6746030
0.040 GeneticVariation BEFREE The A allele of rs6746030 was associated with an altered pain threshold and the effect mediated through C-fiber activation. 20212137

2010

dbSNP: rs11466112
rs11466112
0.030 GeneticVariation BEFREE Recently, a missense point mutation was found in the NGFB gene (C661T, leading to the aminoacid substitution R100W) of individuals affected by a form of hereditary loss of pain perception (hereditary sensory and autonomic neuropathy type V, HSAN V). 19945432

2010

dbSNP: rs165599
rs165599
0.030 GeneticVariation BEFREE The rs165599 SNP, which has previously been associated with response of depressive symptoms to treatment in patients with MDD, did not impact baseline pain in either gender. 20627703

2010

dbSNP: rs2032582
rs2032582
0.020 GeneticVariation BEFREE G2677T/A: The carriers of the variant T allele had a better antinociceptive effect of oxycodone than the carriers of the wild-type genotype in the cold pressor test (25% reduction vs. 15%, P = 0.015 in the discomfort rating and 25% reduction vs. 12%, P = 0.007 in the pain time AUC) and less adverse drug reactions. 19845769

2010

dbSNP: rs748653984
rs748653984
0.020 GeneticVariation BEFREE Recently, a missense point mutation was found in the NGFB gene (C661T, leading to the aminoacid substitution R100W) of individuals affected by a form of hereditary loss of pain perception (hereditary sensory and autonomic neuropathy type V, HSAN V). 19945432

2010

dbSNP: rs778056858
rs778056858
0.020 GeneticVariation BEFREE Recently, a missense point mutation was found in the NGFB gene (C661T, leading to the aminoacid substitution R100W) of individuals affected by a form of hereditary loss of pain perception (hereditary sensory and autonomic neuropathy type V, HSAN V). 19945432

2010

dbSNP: rs1042713
rs1042713
0.010 GeneticVariation BEFREE ADRB2 SNPs rs12654778 and rs1042713 were associated either with CWP alone (p=0.02 for both) or with position along pain spectrum (pain status; p=0.04). 20167428

2010

dbSNP: rs12654778
rs12654778
0.010 GeneticVariation BEFREE ADRB2 SNPs rs12654778 and rs1042713 were associated either with CWP alone (p=0.02 for both) or with position along pain spectrum (pain status; p=0.04). 20167428

2010

dbSNP: rs1378978590
rs1378978590
0.010 GeneticVariation BEFREE Recently, a missense point mutation was found in the NGFB gene (C661T, leading to the aminoacid substitution R100W) of individuals affected by a form of hereditary loss of pain perception (hereditary sensory and autonomic neuropathy type V, HSAN V). 19945432

2010

dbSNP: rs200207721
rs200207721
0.010 GeneticVariation BEFREE However, genetic effects (COMT Val(158)Met and BDNF Val(66)Met) on experimental pain were moderated by the presence of chronic pain. 21049025

2010

dbSNP: rs28935468
rs28935468
0.010 GeneticVariation BEFREE Families of ARSD and InterRett subjects with a C-terminal (OR 2.6; 95% CI 0.8-8.0), p.R168X (OR 2.1; 95% CI 0.7-6.1), or p.R306C (OR 2.7; 95% CI 0.8-9.6) mutation were more likely to report decreased sensitivity to pain. 20425824

2010

dbSNP: rs3813034
rs3813034
0.010 GeneticVariation BEFREE The association between personality, pain threshold and a single nucleotide polymorphism (rs3813034) in the 3'-untranslated region of the serotonin transporter gene (SLC6A4). 20303273

2010

dbSNP: rs4778889
rs4778889
0.010 GeneticVariation BEFREE Our results suggest that the rs4778889 T/C polymorphism of the IL-16 gene may be associated with risk of endometriosis in the Chinese population, especially in patients with pain phenotype. 20662556

2010

dbSNP: rs61748421
rs61748421
0.010 GeneticVariation BEFREE Families of ARSD and InterRett subjects with a C-terminal (OR 2.6; 95% CI 0.8-8.0), p.R168X (OR 2.1; 95% CI 0.7-6.1), or p.R306C (OR 2.7; 95% CI 0.8-9.6) mutation were more likely to report decreased sensitivity to pain. 20425824

2010

dbSNP: rs61751364
rs61751364
0.010 GeneticVariation BEFREE Families of ARSD and InterRett subjects with a C-terminal (OR 2.6; 95% CI 0.8-8.0), p.R168X (OR 2.1; 95% CI 0.7-6.1), or p.R306C (OR 2.7; 95% CI 0.8-9.6) mutation were more likely to report decreased sensitivity to pain. 20425824

2010

dbSNP: rs769540300
rs769540300
0.010 GeneticVariation BEFREE However, genetic effects (COMT Val(158)Met and BDNF Val(66)Met) on experimental pain were moderated by the presence of chronic pain. 21049025

2010

dbSNP: rs769854785
rs769854785
0.010 GeneticVariation BEFREE Recently, a missense point mutation was found in the NGFB gene (C661T, leading to the aminoacid substitution R100W) of individuals affected by a form of hereditary loss of pain perception (hereditary sensory and autonomic neuropathy type V, HSAN V). 19945432

2010